Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Uncontrolled Hypertension in Patients With Type 2 Diabetes: What Are the Correlates? Publisher Pubmed



Rabizadeh S1 ; Gholami B1 ; Mahmoudzadeh Kani S1 ; Rajab A1 ; Farrokhpour H1 ; Esteghamati A1 ; Nakhjavani M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Endocrinology and Metabolism Research Center (EMRC), Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Clinical Hypertension Published:2021


Abstract

Suboptimal blood pressure (BP) control in patients with type 2 diabetes is associated with adverse micro- and macrovascular complications. This study aimed to investigate the predictors of uncontrolled hypertension in an Iranian population with type 2 diabetes. This is a cross-sectional study of 2612 patients with type 2 diabetes, including 944 patients with hypertension. Controlled and uncontrolled hypertension were assessed. Multivariate logistic regression modeling was used to determined independent predictors of uncontrolled hypertension. Of 2612 patients with type 2 diabetes, 944 (36.1%) patients had hypertension. Of all patients with hypertension, 580 (61.4%) were still on monotherapy. Uncontrolled hypertension was detected in 536 participants (56.8%). Patients with uncontrolled hypertension had significantly higher body mass index (BMI) (29.8±4.8 vs. 28.6±4.6), waist circumference (99.11±10.95 vs. 96.68±10.92), pulse pressure (67.3±17.3 vs. 48.4±10.7), total cholesterol (177.1±45.5 vs. 164.3±40.5), non-HDL cholesterol (133.0±43.5 vs. 120.1±38.7), triglycerides (175.7±80.3 vs. 157.4±76.7), and Atherogenic Index of Plasma (AIP) (0.57±0.23 vs. 0.52±0.24) (p <.05 for all of them) compared to patients with controlled hypertension. Multivariate logistic regression analysis revealed that uncontrolled hypertension was significantly associated with BMI (p =.001), pulse pressure (p =.001), total cholesterol (p =.006), and non-HDL cholesterol (p =.009). In patients with triglycerides levels > 200 mg/dl non-HDL cholesterol had a significant correlation with uncontrolled hypertension (OR = 4.635, CI95%:1.781–12.064, p =.002). In conclusion, BMI, pulse pressure, total cholesterol, and non-HDL cholesterol are significant predictors of uncontrolled hypertension in patients with type 2 diabetes. Also, ineffective monotherapy, medical inertia and patients’ non-compliance were other contributors to the uncontrolled hypertension. © 2021 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC
Related Docs
View other Related Docs
1. Empagliflozin Treatment of Cardiotoxicity: A Comprehensive Review of Clinical, Immunobiological, Neuroimmune, and Therapeutic Implications, Biomedicine and Pharmacotherapy (2023)
2. Comparison of Primary Versus Secondary Prevention of Cardiovascular Disease in Patients With Type2 Diabetes: Focus on Achievement of Abc Goals, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2019)
3. The Trend of Risk for Cardiovascular Diseases During the Past Decade in Iran, Applying No-Lab and Lab-Based Prediction Models, Global Heart (2023)
Experts (# of related papers)
View all Related Experts
Alireza Esteghamati (4)
Soghra Rabizadeh (3)
Other Related Docs
4. Cardiovascular and Renal Benefits of Sglt2 Inhibitors: A Narrative Review, International Journal of Endocrinology and Metabolism (2019)
5. Prevalence, Awareness, Treatment and Control of Diabetes Among Iranian Population: Results of Four National Cross-Sectional Stepwise Approach to Surveillance Surveys, BMC Public Health (2022)
6. Agreement Between Mega-Trials and Smaller Trials: A Systematic Review and Meta-Research Analysis, JAMA Network Open (2024)
7. Nationwide Prevalence of Diabetes and Prediabetes and Associated Risk Factors Among Iranian Adults: Analysis of Data From Persian Cohort Study, Diabetes Therapy (2021)
8. A New Model for Optimization of Diabetes Clinics With the Case Study in Iran, Journal of Diabetes and Metabolic Disorders (2022)
9. Type 2 Diabetes Burden and Diabetes Distress: The Buffering Effect of Patient-Centred Communication, Canadian Journal of Diabetes (2022)
10. Inadequate Achievement of Abc Goals (Hba1c, Blood Pressure, Ldl-C) Among Patients With Type 2 Diabetes in an Iranian Population, 2012–2017, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2020)
11. Bioactive Foods and Medicinal Plants for Cardiovascular Complications of Type Ii Diabetes: Current Clinical Evidence and Future Perspectives, Evidence-based Complementary and Alternative Medicine (2021)
12. Iranian National Clinical Practice Guideline for Exercise in Patients With Diabetes, International Journal of Endocrinology and Metabolism (2021)
13. Economic Evaluation of a National Vitamin D Supplementation Program Among Iranian Adolescents for the Prevention of Adulthood Type 2 Diabetes Mellitus, BMC Complementary Medicine and Therapies (2022)
14. Efficacy and Safety of Insulin Detemir Versus Glargine in Patients With Diabetes: A Systematic Review and Meta-Analysis, Expert Review of Clinical Pharmacology (2022)
15. Challenges in Providing Care for Patients With Chronic Diseases During Disasters: A Qualitative Study With Focus on Diabetes and Chronic Respiratory Diseases in Iran, Tanaffos (2023)
16. Burden of Type 2 Diabetes Mellitus and Its Risk Factors in North Africa and the Middle East, 1990–2019: Findings From the Global Burden of Disease Study 2019, BMC Public Health (2024)